26x P/E for 30% Earnings Growth: Is Alphabet a Value Play Now?

Technology

BridgeBio Secures Attruby Approval, Triggers Price Target Hikes

Life Science

Plant-Based Meat Giant Beyond Meat Rebrands to Expand Beyond Its Core, Posts Record Low Revenue Since Listing in 2025 

Consumer Goods

Nvidia Invests in a “Competitor”—What Does Marvell Hold That the AI Giant Needs?

Technology

Gold Stocks Refuse to Follow Gold’s Steepest Monthly Slump Since 2008 — Is the Tide Turning?

Precious Metals

Impressive Performance Yet Low Stock Price, Can Eli Lilly Usher in a Turning Point with Medicare Coverage?

Life Science

This Popular ETF Quietly Boosted Its Healthcare Stake – High-Yield Dividend Stocks Are the New Favorite

Life Science

US Treasury Bonds Staged a Strong Rebound as Market Focus Shifted from Inflationary Shocks to Concerns Over an Economic Recession

Financial Service

Deep Pullback in Tech Stocks a Buying Opportunity? Analysts Identify “Purchase List”

Technology

Nasdaq Enters Correction: These 3 Growth Stocks Might Be a Once-in-a-Decade Buying Opportunity

Technology

Micron and Sandisk Plunge: Is Google’s TurboQuant Algorithm Really That Scary?

Technology

The Dividend Power Play: 5 Pipeline Stocks Yielding No Less Than 4.5%

Energy

Viking Therapeutics Approaches Make-or-Break Moment as Key GLP-1 Data Looms

Life Science

Rocket Lab or Redwire? Which Is the Better Lunar Infrastructure Investment Play?

Technology

Micron’s Explosive Earnings Blowout: Why Wall Street Missed the Mark Completely

Technology